---
title: "Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | RNA Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/283429396.md"
description: "Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | RNA Stock News"
datetime: "2026-04-20T18:50:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283429396.md)
  - [en](https://longbridge.com/en/news/283429396.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283429396.md)
---

# Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | RNA Stock News

Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | RNA Stock News

### Related Stocks

- [RNA.US](https://longbridge.com/en/quote/RNA.US.md)
- [NDAQ.US](https://longbridge.com/en/quote/NDAQ.US.md)

## Related News & Research

- [Atrium Therapeutics Reports First Quarter 2026 Financial Results | RNA Stock News](https://longbridge.com/en/news/286465472.md)
- [Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)](https://longbridge.com/en/news/286814879.md)
- [Wave Life Sciences ATS Data Could Support RNA Editing Platform, Wedbush Says](https://longbridge.com/en/news/286602718.md)
- [CAMP4 Highlights Preclinical Progress of SYNGAP1 Therapy](https://longbridge.com/en/news/286426973.md)
- [Codexis spotlights siRNA stereochemistry control at TIDES USA 2026](https://longbridge.com/en/news/287070986.md)